FA vs VRTX · P/E 318, rev $860.2M vs P/E 30, rev $12.00B
First Advantage Corp (FA) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
First Advantage Corp (FA) is a specialty business services company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported FA revenue for 2024-12-31 was $860.2M. Net income was -$110.3M. Revenue was up 12.6% from 2023-12-31 to 2024-12-31. FA currently screens at market cap $2.72B and trailing P/E 317.6.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
FA currently screens at market cap $2.72B and trailing P/E 317.6. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the FA and VRTX stock pages for the full models.
Not investment advice.